LumiraDx Limited (LMDXW) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Diagnostics & Research industria. La empresa tiene su sede en London, United Kingdom. El CEO actual es Veronique Ameye EMBA,.
LMDXW tiene fecha de IPO 2021-09-29, 1,210 empleados a tiempo completo, cotiza en el NASDAQ Global Market, una capitalización de mercado de $5.1M.
LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.
